Calithera Biosciences Announces Telaglenastat KEAPSAKE Trial in Progress Abstract Accepted for Presentation at ASCO20 Virtual Annual Meeting

NEXT STORY
Athenex 宣佈 ASCO20 虛擬科學計劃將接受口服紫杉醇二期血管肉瘤研究
PREV STORY
Children Believe Helps Children Stay Safe and Learn During COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PHASE 3 DATA ON FILGOTINIB IN BIOLOGIC-EXPERIENCED RHEUMATOID ARTHRITIS TO BE PRESENTED AT 2018 ACR/ARHP ANNUAL MEETING

-- FINCH 2 Study Results Demonstrate Significant Improvement in Rheumatoid Arthritis Signs, Symptoms and ...

author_avatar
NASDAQ Market News

Chimerix Appoints Randall Lanier, PhD as Chief Science Officer, and Roy W. Ware, PhD, MBA as Chief Manufacturing and Technology Officer

DURHAM, N.C., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company discovering, ...

author_avatar
NASDAQ Market News

Ronald Martell to Join Cytori Therapeutics’ Board of Directors

SAN DIEGO, Dec. 28, 2016 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) (“Cytori” or the ...

author_avatar
NASDAQ Market News